Literature DB >> 25371180

Cbfb deficiency results in differentiation blocks and stem/progenitor cell expansion in hematopoiesis.

C Q Wang1, D W L Chin2, J Y Chooi2, W J Chng2, I Taniuchi3, V Tergaonkar4, M Osato5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25371180     DOI： 10.1038/leu.2014.316

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.

Authors:  Ichiro Taniuchi; Motomi Osato; Takeshi Egawa; Mary Jean Sunshine; Suk Chul Bae; Toshihisa Komori; Yoshiaki Ito; Dan R Littman
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

Review 2.  Core-binding factors in haematopoiesis and leukaemia.

Authors:  Nancy A Speck; D Gary Gilliland
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

3.  Runx3 deficiency results in myeloproliferative disorder in aged mice.

Authors:  Chelsia Qiuxia Wang; Lena Motoda; Masanobu Satake; Yoshiaki Ito; Ichiro Taniuchi; Vinay Tergaonkar; Motomi Osato
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

4.  Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.

Authors:  Joseph D Growney; Hirokazu Shigematsu; Zhe Li; Benjamin H Lee; Jennifer Adelsperger; Rebecca Rowan; David P Curley; Jeffery L Kutok; Koichi Akashi; Ifor R Williams; Nancy A Speck; D Gary Gilliland
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

5.  Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.

Authors:  R Katherine Hyde; Yasuhiko Kamikubo; Stacie Anderson; Martha Kirby; Lemlem Alemu; Ling Zhao; P Paul Liu
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

6.  Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.

Authors:  Bindya Jacob; Motomi Osato; Namiko Yamashita; Chelsia Qiuxia Wang; Ichiro Taniuchi; Dan R Littman; Norio Asou; Yoshiaki Ito
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

7.  Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

Authors:  Krzysztof Mrózek; Guido Marcucci; Deedra Nicolet; Kati S Maharry; Heiko Becker; Susan P Whitman; Klaus H Metzeler; Sebastian Schwind; Yue-Zhong Wu; Jessica Kohlschmidt; Mark J Pettenati; Nyla A Heerema; AnneMarie W Block; Shivanand R Patil; Maria R Baer; Jonathan E Kolitz; Joseph O Moore; Andrew J Carroll; Richard M Stone; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

Review 8.  Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.

Authors:  Motomi Osato
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

9.  Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.

Authors:  Ya-Huei Kuo; Sean F Landrette; Susan A Heilman; Paola N Perrat; Lisa Garrett; Pu P Liu; Michelle M Le Beau; Scott C Kogan; Lucio H Castilla
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 38.585

10.  Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.

Authors:  Michael J Chen; Tomomasa Yokomizo; Brandon M Zeigler; Elaine Dzierzak; Nancy A Speck
Journal:  Nature       Date:  2009-01-07       Impact factor: 49.962
View more
  8 in total

Review 1.  The RUNX complex: reaching beyond haematopoiesis into immunity.

Authors:  Dominic Chih-Cheng Voon; Yit Teng Hor; Yoshiaki Ito
Journal:  Immunology       Date:  2015-10-25       Impact factor: 7.397

Review 2.  Mouse models for core binding factor leukemia.

Authors:  D W L Chin; N Watanabe-Okochi; C Q Wang; V Tergaonkar; M Osato
Journal:  Leukemia       Date:  2015-07-13       Impact factor: 11.528

Review 3.  Emerging therapies for inv(16) AML.

Authors:  Sridevi Surapally; Daniel G Tenen; John A Pulikkan
Journal:  Blood       Date:  2021-05-13       Impact factor: 22.113

4.  Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB.

Authors:  Maaike G J M van Bergen; Joline L Saes; Annet Simons; Konnie M Hebeda; Yvonne M C Henskens; Wideke Barteling; Erik Huys; Britta A P Laros-van Gorkom; Saskia E M Schols; Frank W Preijers; Marjolijn C J Jongmans; Joop H Jansen; Bert A van der Reijden
Journal:  Am J Hematol       Date:  2020-04-08       Impact factor: 10.047

5.  MiR-34b inhibits the proliferation and promotes apoptosis in colon cancer cells by targeting Wnt/β-catenin signaling pathway.

Authors:  Kailun Ye; Chunhua Xu; Tongguan Hui
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

6.  Alleviation of skin inflammation after Lin(-) cell transplantation correlates with their differentiation into myeloid-derived suppressor cells.

Authors:  Su Jeong Ryu; Ji-Min Ju; Woojin Kim; Min Bum Kim; Kuen Hee Oh; Dong Sup Lee; Hakmo Lee; Ju Eun Oh; Kyong Soo Park; Eun Young Choi
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

Review 7.  Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia.

Authors:  Federico Mosna; Michele Gottardi
Journal:  Stem Cells Int       Date:  2016-01-13       Impact factor: 5.443

8.  Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking.

Authors:  Joshua T Rose; Eliana Moskovitz; Joseph R Boyd; Jonathan A Gordon; Nicole A Bouffard; Andrew J Fritz; Anuradha Illendula; John H Bushweller; Jane B Lian; Janet L Stein; Sayyed K Zaidi; Gary S Stein
Journal:  Oncotarget       Date:  2020-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.